Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy

Autor: Daan Dierickx, Charlotte Maggen, Petronella B. Ottevanger, Andie O'Laughlin, Alvaro Cabrera-Garcia, Bianca Masturzo, Elyce Cardonick, Johannes J. Duvekot, Mina Mhallem Gziri, Evgeniya Polushkina, Roman G. Shmakov, Frédéric Amant, Irit Avivi, F J Sherida H Woei-A-Jin, Kristel Van Calsteren

Publikováno v: British Journal of Haematology, 193, 52-62
British Journal of Haematology, 193, 1, pp. 52-62
British journal of haematology, Vol. 193, no. 1, p. 52-62 (2021)
British Journal of Haematology
British journal of haematology, 193(1), 52-62. Wiley-Blackwell

This cohort study of the International Network on Cancer, Infertility and Pregnancy (INCIP) reports the maternal and neonatal outcomes of 80 pregnant patients diagnosed with non-Hodgkin lymphoma (NHL) between 1986 and 2019, focussing on 57 (71%) pati

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7604016ccbe3406f7e1a83302eaea1b
https://hdl.handle.net/2066/232066

Rare Diagnosis in a Patient with Diabetes with Nephrotic Proteinuria

Autor: Mário Góis, Patricia Cotovio, Ariana Azevedo, Fernando Nolasco

Publikováno v: BMJ Case Rep

We report a 63-year-old man with well-controlled type 2 diabetes mellitus and hypertension, who presented with new onset nephrotic proteinuria and rapid deterioration in renal function. The atypical clinical presentation prompted us to consider a non

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1815ec771f7d1e9200cdc1292b890d91
https://hdl.handle.net/10400.17/4064

Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy

Autor: Lobatto, Mark E., Calcagno, Claudia, Otten, Maarten J., Millon, Antoine, Ramachandran, Sarayu, Paridaans, Maarten P M, van der Valk, Fleur M., Storm, G, Stroes, Erik S G, Fayad, Zahi A., Mulder, Willem J M, Metselaar, Josbert M., Pharmaceutics, Sub Drug targeting, Sub General Pharmaceutics

Publikováno v: Nanomedicine: Nanotechnology, Biology and Medicine
Nanomedicine: Nanotechnology, Biology and Medicine, Elsevier, 2015, 11 (5), pp.1133-40. ⟨10.1016/j.nano.2015.02.020⟩
Nanomedicine: nanotechnology, biology and medicine, 11(5), 1133-1140. Elsevier Inc.
Nanomedicine, 11(5), 1133-1140. Future Medicine Ltd.
Nanomedicine : nanotechnology, biology and medicine, 11(5), 1133. Elsevier

International audience; The present study describes the development of a good manufacturing practice (GMP)-grade liposomal nanotherapy containing prednisolone phosphate for the treatment of inflammatory diseases. After formulation design, GMP product

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79ed09ed8f998ca03ede8ef7ef7a4a7
https://doi.org/10.1016/j.nano.2015.02.020

Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

Autor: Joanna Gale, C.L. Ferguson, J. Martin Russell, Prabir Chakraborti, Carys Thomas, Mohan Hingorani, Joe M. O'Sullivan, Anjali Zarkar, Clare Gilson, Zafar Malik, John Wagstaff, Jo Bowen, Fiona McKinna, Angus Robinson, Claire Amos, Simon Chowdhury, Alison Birtle, Fawzi Adab, Peter Hoskin, San Aung, Robin Millman, Chris Parker, Neil McPhail, Alastair W. S. Ritchie, Robert Jones, Jason F. Lester, Noel W. Clarke, Susannah Brock, Gerhardt Attard, Andrew Protheroe, James D. Wylie, Omi Parikh, Johann S. de Bono, Nicholas D. James, Julian Money-Kyrle, Malcolm David Mason, William Cross, Emma Gray, David Matheson, Dominik Berthold, Silke Gillessen, Melissa R. Spears, David P. Dearnaley, Narayanan Srihari, Matthew R. Sydes, Mahesh K.B. Parmar, Chris Brawley

Publikováno v: STAMPEDE investigators 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
STAMPEDE Investigators & Gillessen, S 2017, ' Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy ', The New England Journal of Medicine, vol. 377, no. 4, pp. 338-351 . https://doi.org/10.1056/NEJMoa1702900
The New England journal of medicine, vol. 377, no. 4, pp. 338-351

BACKGROUND: Abiraterone acetate plus prednisolone improves survival in men with relapsed prostate cancer. We assessed the effect of this combination in men starting long-term androgen-deprivation therapy (ADT), using a multigroup, multistage trial de

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae654176b4379045bb5aaa6609f18434
https://pure.qub.ac.uk/en/publications/bca063cc-7a5e-46eb-95d8-7e27f2cf88b6

Discontinuation of steroids in ABO-incompatible renal transplantation

Autor: Marija Kristina Novosel, Claus Bistrup

Publikováno v: Novosel, M K & Bistrup, C 2016, ' Discontinuation of steroids in ABO-incompatible renal transplantation ', Transplant International, vol. 29, no. 4, pp. 464-470 . https://doi.org/10.1111/tri.12735

A steroid-free protocol for ABO-compatible renal transplantation has been used at our center since 1983. To minimize the adverse effects of steroids, we also developed a steroid sparing protocol for ABO-incompatible renal transplantation in 2008. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23f177049098359eb6252ad20f71c10
https://portal.findresearcher.sdu.dk/da/publications/a094835c-3eb8-451a-a685-c9e02285dac5